Hormones: A Comprehensive Guide for Thyroid Optimization

Learn about thyroid optimization for hormones and their vital role in your health. Optimize your thyroid for improved vitality and balance.

Abstract

I wrote this educational post to share how I evaluate and treat persistent hypothyroid symptoms when traditional, TSH-centered therapy falls short. Drawing on my personal journey of living without a thyroid and more than a decade in integrated clinical practice, I explain why patients can feel hypothyroid with “normal” lab values, how the deiodinase system and reverse T3 shape symptoms, and where free T3 offers a more reliable clinical compass. I also detail why some people do better on combination T4/T3 therapy or desiccated thyroid, how nutrient cofactors like iron and selenium transform outcomes, and why lab timing and dose splitting matter. I show where integrative chiropractic care fits by improving autonomic balance, pain, sleep, and movement capacity—factors that directly influence hormone conversion and tissue response. Throughout, I integrate modern, evidence-based research and reference leading studies in endocrinology, cardiology, neurology, and rehabilitation. You will find a precise, step-by-step framework to help patients move from biochemical uncertainty to functional recovery.

The Journey Without a Thyroid and How It Shapes My Care

I practice medicine and chiropractic with a unique perspective. Many patients were required to complete thyroid removal. In the era before recombinant TSH, I experienced diagnostic withdrawal phases that pushed my TSH above 150 mIU/L. They felt the hard edge of metabolic shutdown—cold intolerance, constipation, bradypsychia (slowed thinking), and the kind of profound fatigue that flattens life.

Those deeply personal experiences transformed how I listen to and care for patients. Over the last 14 years, I have provided longitudinal care for more than 9,000 patients with thyroid-related conditions. I repeatedly see the gap between “lab-normal” and truly feeling normal in daily life. Many arrive with TSH values in range on levothyroxine yet still grapple with persistent symptoms.

In my chiropractic practice, I integrate precise spinal adjustments to optimize nervous system function and autonomic balance, thereby directly supporting endocrine regulation and helping close that gap. Patients often describe the full spectrum of thyroid imbalance: classic hypothyroid effects such as fatigue, weight gain, hair thinning, low mood or depression, brain fog, slowed cognition, dry skin, muscle weakness, constipation, cold intolerance, and exercise intolerance; as well as disruptive hyperthyroid symptoms including unintended weight loss despite increased appetite, heat intolerance, anxiety or irritability, rapid heartbeat or palpitations, diarrhea, tremors, restlessness, insomnia, and excessive sweating.

Many therapeutic journeys have reached the same conclusion: many patients need a more nuanced approach than T4 replacement alone—sometimes adding T3, correcting nutrient gaps, addressing gut-liver dysfunction, or resolving autonomic imbalance. These lived lessons anchor the whole-person framework I share here.
References for clinical updates and case observations:
ChiroMed: https://chiromed.com/
LinkedIn: https://www.linkedin.com/in/dralexjimenez/

Thyroid Physiology And Why A Normal TSH Can Mask Low Tissue Thyroid Action

To fully explain persistent symptoms, I begin with the hypothalamic-pituitary-thyroid (HPT) axis and tissue-level control:

• The hypothalamus releases TRH, prompting the pituitary to release TSH, which signals the thyroid to make T4 and T3.
• T3 is the bioactive hormone that binds to nuclear thyroid receptors (TRα, TRβ), upregulates mitochondrial and metabolic genes, and drives energy production.
• Most circulating T3 is made in peripheral tissues by deiodinases. D1 and D2 convert T4 to T3, while D3 shunts T4 into reverse T3 (rT3)—an inactive isomer that competes with T3 for receptor access.

When inflammation, stress, or nutrient deficiency suppress D1 and favor D3, the result is a “low T3–high rT3” pattern. The pituitary, cushioned by local D2 activity, may “feel” replete and keep TSH within range, while muscles, brain, liver, and heart remain T3-deficient. This is how people feel hypothyroid despite a “normal” TSH.

• Deiodinase and tissue signaling overview: (Bianco & Kim, 2018)
• Non-thyroidal illness and low T3 physiology: (Peeters, 2017)
• Transporter and receptor influences on intracellular signaling: (Friesema et al., 2010)

Citations:

• Bianco, A. C., & Kim, B. W. (2018). Deiodinases and the control of thyroid hormone signaling and metabolism. The Journal of Clinical Endocrinology & Metabolism.
• Peeters, R. P. (2017). Non-thyroidal illness: To treat or not to treat. Nature Reviews Endocrinology.
• Friesema, E. C. H., et al. (2010). Thyroid hormone transporters. Clinical Endocrinology.

Why Free T3 Predicts Function Better Than TSH During Treatment

In practice and research, free T3 correlates more tightly with energy, thermoregulation, cognition, and cardiometabolic outcomes than TSH when therapy is underway. While TSH is an excellent screening tool in untreated populations, it does not reliably reflect tissue thyroid status once exogenous hormone is introduced. Peripheral tissues depend on D1, which is easily downregulated by stress and illness. The pituitary’s reliance on D2 allows TSH to normalize even as free T3 remains low or rT3 rises.

• Cardiovascular findings consistently link low T3 with worse outcomes; TSH often shows weak or no association (Dimitriadis et al., 2014; Iervasi et al., 2010).
• In critical illness and ARDS, low T3 predicts higher mortality and delayed recovery (Wajner & Maia, 2015).

Citations:

• Dimitriadis, G., et al. (2014). Thyroid hormone actions in the cardiovascular system. Heart, Lung, and Circulation.
• Iervasi, G., et al. (2010). Low triiodothyronine syndrome and mortality risk in cardiac patients. The Journal of Clinical Endocrinology & Metabolism.
• Wajner, S. M., & Maia, A. L. (2015). Thyroid function and outcomes in critical illness and ARDS. Critical Care.

The Reverse T3 Brake And The Conversion Ecology

I teach patients to think of reverse T3 as a physiologic brake. Under stress, inflammation, infection, caloric restriction, or high T4 loads, D3 increases and shunts T4 into rT3. Elevated rT3 effectively blocks T3’s action by competing for receptor and transport access.

• Symptoms of high rT3/low T3: fatigue, cold intolerance, constipation, dry skin, sluggish thinking, reduced exercise tolerance.
• Clinical reasoning: Adding more T4 in a high rT3 state often worsens the problem by feeding the brake. We must address stressors, reduce inflammation, optimize cofactors, and, when indicated, add physiologic T3.

Mechanistic reviews:

• Bianco, A. C., & Kim, B. W. (2018). Deiodinases and the control of thyroid hormone signaling and metabolism. The Journal of Clinical Endocrinology & Metabolism.

Levothyroxine Alone: When The Assumptions Fail

The traditional assumption was that T4-only therapy would convert adequately to T3 and fully resolve symptoms. Many patients do improve on levothyroxine. Yet a meaningful proportion remain symptomatic because of impaired conversion or high rT3.

• Genetic polymorphisms (e.g., DIO2 Thr92Ala) and inflammatory states alter T3 production and action (Panicker et al., 2009).
• Caloric restriction, illness, and iron deficiency shift deiodinase activity away from T3 (Stott et al., 2019).

A physiologic alternative is to use combination therapy (T4 + T3) or desiccated thyroid (DTE) for select patients with persistent symptoms, carefully titrated and monitored for safety.
Citations:

• Panicker, V., et al. (2009). Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy. The Journal of Clinical Endocrinology & Metabolism.
• Stott, D. J., et al. (2019). Thyroid hormone therapy for older adults with subclinical hypothyroidism. The New England Journal of Medicine.
• Hoang, T. D., et al. (2013). Desiccated thyroid extract compared with levothyroxine. The Journal of Clinical Endocrinology & Metabolism.

The Testosterone Connection And Metabolic Synergy

Thyroid hormones and androgens co-regulate metabolic rate, muscle protein synthesis, and mitochondrial efficiency:
Hypothyroidism can downregulate androgen receptors; low testosterone reduces muscle mass and worsens fatigue (Kelly & Jones, 2015).

• Thyroid hormones increase SHBG, thereby altering the free fractions of testosterone and estradiol (Davis & Wahlin-Jacobsen, 2015).
• Visceral adiposity increases aromatase activity, further lowering free testosterone. Optimizing thyroid action reduces central fat and indirectly improves androgen balance.

Citations:

• Kelly, D. M., & Jones, T. H. (2015). Testosterone and obesity. Clinical Endocrinology.
• Davis, S. R., & Wahlin-Jacobsen, S. (2015). Testosterone in women: the clinical significance. Clinical Endocrinology.

An Evidence-Guided Evaluation Framework I Use In Clinic

To identify root causes of persistent symptoms, I apply a structured model:

• Comprehensive thyroid panel and dynamics
  • TSH, free T4, free T3, and reverse T3 to map supply, conversion, and braking.
  • Thyroid antibodies (TPOAb, TgAb) for autoimmunity surveillance.
  • Consistent lab timing relative to dosing.
• Nutrient and hematologic status
  • Ferritin, iron indices, selenium, zinc, vitamin D, vitamin A, B12; iodine assessment when indicated and carefully monitored.
  • Rationale: cofactors enable hormone synthesis and conversion (Zimmermann & Köhrle, 2002).
• Inflammation and metabolic health
  • hsCRP, fasting insulin, HOMA-IR, lipids, liver enzymes; body composition for lean mass and visceral fat.
• Gut-liver axis
  • Screen dysbiosis/SIBO symptoms, celiac markers, NAFLD risk, bile flow, and constipation patterns (Docimo et al., 2021).
• Autonomic nervous system and stress load
  • HRV, orthostatic vitals, sleep quality, perceived stress.
• Sex hormones and adrenal rhythm (as indicated)
  • Total and free testosterone, SHBG, estradiol, LH/FSH; DHEA-S; consider cortisol profiles when warranted.

Citations:

• Zimmermann, M. B., & Köhrle, J. (2002). The impact of iron and selenium deficiencies on iodine and thyroid metabolism. Endocrine Reviews.
• Docimo, G., et al. (2021). Thyroid hormones, bile acids, and microbiota: An intriguing triangle. Nutrients.

Precision Dosing: Why Lab Timing And Dose Splits Matter

When I incorporate T3 (liothyronine) or use desiccated thyroid, I standardize lab draws at five to six hours after the morning dose and split doses to avoid peaks:

• Pharmacokinetics: Oral T3 peaks about 1–2 hours after ingestion and declines over the next several hours. Drawing at 5–6 hours captures a mid-curve snapshot that is comparable across visits (Ross, 2022; Jonklaas et al., 2019).
• Dose splitting: I typically use BID or TID schedules (e.g., 6:00 a.m., 12:00 p.m., 6:00 p.m.) to maintain steady intracellular T3 for mitochondrial throughput, cognitive function, and thermoregulation. This dramatically reduces palpitations and anxiety tied to early peaks.
• Wearables: I ask patients to track heart rate and sleep. Post-dose pulse spikes confirm kinetic peaks and guide redistribution.

Citations:

• Ross, D. S. (2022). Liothyronine (T3) pharmacology and physiological actions. Endotext, NCBI Bookshelf.
• Jonklaas, J., et al. (2019). Thyroid hormone therapy and pharmacokinetics: Clinical considerations. The Journal of Clinical Endocrinology & Metabolism.

Combination Therapy And Desiccated Thyroid: How I Use Them And Why

I consider combination T4/T3 or desiccated thyroid extract (DTE) for patients with persistent symptoms and a lab pattern of low free T3 and/or elevated rT3:

• Start low and titrate slowly
  • Introduce small, divided T3 doses to avoid peak-related side effects.
  • Maintain a baseline T4 level for substrate, while ensuring receptor activation by T3.
• DTE practicals
  • Typical starting range: 1–1.5 grains (60–90 mg) daily, individualized to prior T4 dose and sensitivity.
  • Transition approach: a two-week half-and-half overlap (half prior T4 dose plus half new DTE dose) to avoid T3-naïve jitters.
  • Limit large single doses; distribute across the day if a higher total daily dose is needed.
• Monitoring
  • Symptoms, free T3, free T4, and safety markers (heart rate, blood pressure).
  • Long-term: bone density surveillance when higher T3 exposures are used in specific populations.

Evidence-based and patient preference data:

• Hoang, T. D., et al. (2013). Desiccated thyroid extract compared with levothyroxine. The Journal of Clinical Endocrinology & Metabolism.
• Dayan, C. M., & Panicker, V. (2018). Hypothyroidism and depression. Clinical Endocrinology.

Nutrient Therapy That Changes Outcomes: The Thyroid

The thyroid hormone is a signal, but the body needs substrates and cofactors to translate that signal into action. I routinely assess and treat:

• Iron repletion when ferritin is low (often targeting >50–70 ng/mL for thyroid optimization)
  • Iron supports thyroid peroxidase and deiodinase function; low ferritin levels blunt T4-to-T3 conversion and can mimic hypothyroid symptoms.
• Selenium (100–200 mcg/day from diet/supplement)
  • Supports deiodinase activity and antioxidant defense; may modestly reduce TPO antibodies (Winther et al., 2020).
• Zinc, vitamin D, vitamin A, and B12
  • Zinc facilitates receptor function; vitamin D modulates immune tone and muscle; vitamin A supports epithelial and receptor dynamics.
• Protein sufficiency (often 1.2–1.6 g/kg/day)
  • Supports thyroid transport proteins, hepatic conversion, and muscle mass.

Citations:

• Winther, K. H., et al. (2020). Selenium in thyroid disorders. The Journal of Clinical Endocrinology & Metabolism.
• Zimmermann, M. B., & Köhrle, J. (2002). The impact of iron and selenium deficiencies on iodine and thyroid metabolism. Endocrine Reviews.

Integrative Chiropractic Care: Autonomic Regulation, Pain Reduction, And Metabolic Performance

As a DC and APRN, I see daily how neuromusculoskeletal health and the autonomic nervous system shape endocrine outcomes. Integrative chiropractic care fits into thyroid optimization by:

• Autonomic regulation
  • Gentle spinal manipulation and soft-tissue techniques reduce nociceptive input and sympathetic overdrive, improving vagal tone and HRV. Lower stress signaling supports D1 activity, reduces rT3, and improves sleep quality.
• Pain reduction
  • By reducing chronic pain, we lower inflammatory cytokines (e.g., IL-6, TNF-α) that suppress deiodinases and disrupt sleep, thereby enabling better hormone conversion and tissue responses.
• Movement-based care
  • Structured resistance training and aerobic intervals, guided by movement assessment, improve insulin sensitivity, GLUT-4 translocation, and mitochondrial density, amplifying T3’s metabolic impact.
• Breath and posture
  • Thoracic mobility and diaphragmatic breathing enhance oxygenation, vagal tone, and sleep—key supports for endocrine stability.

Clinical observations:
In my practice at ChiroMed, patients who pair optimized thyroid therapy with chiropractic autonomic optimization, mobility work, and progressive strength programming recover faster, maintain better energy, and sustain fat loss more reliably. See clinical reflections and case pearls:

• ChiroMed: https://chiromed.com/

• LinkedIn: https://www.linkedin.com/in/dralexjimenez/

Metabolic Rehabilitation: Building A Physiology That Welcomes T3

Thyroid optimization alone rarely solves modern metabolic challenges. I employ a pragmatic blueprint:

• Build muscle first
  • Two or more weekly full-body resistance training sessions with progressive overload. More muscle equals a higher basal metabolic rate and better glucose disposal.
• Walk the thermostat
  • 7,000–10,000+ daily steps, with postprandial 10–15-minute brisk walks, to blunt glucose excursions and lower inflammation.
• Prioritize sleep and rhythm.m
  • Stable sleep-wake times, morning light exposure, and evening light reduction improve HPT-axis signaling and insulin sensitivity.
• Protein-forward nutrition
  • 25–40 g protein per meal; fiber-rich plants and healthy fats; minimize ultra-processed foods.
• Micronutrient sufficiency
  • Emphasize seafood (selenium, iodine), lean meats (iron, zinc, B12), eggs (vitamin A), and leafy greens (folate, magnesium).
• Stress modulation
  • Breathing practices, HRV-guided recovery, and time in nature lower cortisol and rT3.
• Manual and chiropractic care
  • Identify and correct joint restrictions and postural dysfunctions that limit training and raise sympathetic tone.

Epidemiologic context: U.S. obesity prevalence continues to rise, underscoring the need to embed thyroid care within a broader metabolic strategy (CDC, 2023).
Citation:

• CDC. (2023). Adult Obesity Prevalence Maps. Centers for Disease Control and Prevention.

Thyroid Dysfunction-Video

Safety And Monitoring: Cardiac And Bone Health With T3

I titrate T3 conservatively and monitor:

• Cardiac status (resting pulse, symptoms; ECG as indicated in arrhythmia-prone patients).
• Bone health (ensure adequate calcium and vitamin D, prioritize resistance training, and follow DEXA for at-risk individuals).
• Symptoms and function (energy, thermoregulation, bowel rhythm, cognition, sleep).
• Free T3/Free T4, with TSH interpreted cautiously under T3-containing regimens.

A key clinical distinction: TSH suppression on therapy is not the same as endogenous hyperthyroidism. In thyroid cancer cohorts, carefully managed TSH suppression does not universally increase atrial fibrillation or osteoporosis risk when free hormones and clinical markers are appropriately monitored. We individualize targets rather than relying on a single lab threshold.
Reviews:

• Biondi, B., & Cooper, D. S. (2014). Subclinical thyroid dysfunction and cardiovascular risk: A nuanced view. JAMA.

Standardizing Testing: Reducing Noise And Improving Decisions

The most powerful lever in precision thyroid care is standardization:

• Fix dosing times (e.g., 6:00 a.m., 12:00 p.m., 6:00 p.m.).
• Lock blood draws at five to six hours after the morning dose.
• If patients arrive outside the window, reschedule to keep results comparable.
• Use simple EMR notes to track outcomes: “Free T3 improved; patient reports better focus and energy; no adverse effects at standard draw; pulse stable.”

This rigor transforms guesswork into reliable, reproducible decisions.
Citations:

• Jonklaas, J., et al. (2019). Thyroid hormone therapy and pharmacokinetics: Clinical considerations. The Journal of Clinical Endocrinology & Metabolism.

Case Patterns From Practice: How The Physiology Plays Out

The “stuck but strict” patient

• A woman on levothyroxine with normal TSH but persistent fatigue and weight gain. Ferritin was 18 ng/mL; vitamin D was 22 ng/mL; rT3 was elevated. After iron and vitamin D repletion, post-meal walking, and low-dose T3 add-on, energy rose within weeks. Resistance training resulted in a 6% relative reduction in body fat over four months; we later tapered levothyroxine as conversion normalized.

The “pain-metabolism loop.”

• A man with low back pain avoided exercise and gained weight while on stable thyroid replacement therapy. Integrative chiropractic care reduced pain and improved mobility. We added a graded strength plan and sleep coaching; HRV improved. With modest T3 addition, he reported clearer thinking and greater stamina.

The”testosterone trap.”

• A man sought testosterone for fatigue and low libido. Evaluation revealed low-normal free T3, elevated rT3, high stress, and poor sleep. We prioritized thyroid optimization, sleep, and resistance training. Free testosterone improved without exogenous testosterone; symptoms resolved.

Clinical notes and similar cases:

• ChiroMed: https://chiromed.com/
• LinkedIn: https://www.linkedin.com/in/dralexjimenez/

Practical Steps For Patients And Clinicians

Patients

• Ask for a comprehensive thyroid panel: TSH, free T4, free T3; consider reverse T3 if symptoms persist.
• Check ferritin, selenium, zinc, vitamin D, and B12; discuss iodine only with clinical guidance.
• Standardize dosing times and lab draw timing; split doses if needed to reduce peaks.
• Build muscle, walk after meals, and protect sleep; track pulse and sleep with wearables if possible.
• Consider integrative chiropractic care to improve pain, autonomic balance, and movement capacity.

Clinicians

• Treat the person, not just the lab. If symptoms persist with “normal” TSH, investigate conversion ecology, cofactors, and comorbidities.
• Consider cautious T4/T3 combination or DTE trials with standardized monitoring and safety tracking.
• Pair endocrine therapy with nutrition, sleep, stress care, and chiropractic/rehab partners.
• Reassess as inflammation, body composition, and fitness improve; the right dose today may be excessive in six months.

Closing Perspective: Aligning Therapy With Physiology

Living without a thyroid taught me respect for the complexity of endocrine physiology and the limits of single-number thinking. Care improves when we align therapy with how the body actually works: ensure adequate hormone supply; correct cofactor deficiencies; calm the autonomic nervous system; build muscle; and remove friction points such as pain, inflammation, and poor sleep. When we combine personalized thyroid replacement, targeted nutrient therapy, and integrative chiropractic care within a metabolic rehabilitation framework, patients stop treading water and begin moving forward.

References

• Bianco, A. C., & Kim, B. W. (2018). Deiodinases and the control of thyroid hormone signaling and metabolism. The Journal of Clinical Endocrinology & Metabolism.
• Peeters, R. P. (2017). Non-thyroidal illness: To treat or not to treat. Nature Reviews Endocrinology.
• Friesema, E. C. H., et al. (2010). Thyroid hormone transporters. Clinical Endocrinology.
• Dimitriadis, G., et al. (2014). Thyroid hormone actions in the cardiovascular system. Heart, Lung, and Circulation.
• Iervasi, G., et al. (2010). Low triiodothyronine syndrome and mortality risk in cardiac patients. The Journal of Clinical Endocrinology & Metabolism.
• Wajner, S. M., & Maia, A. L. (2015). Thyroid function and outcomes in critical illness and ARDS. Critical Care.
• Panicker, V., et al. (2009). Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy. The Journal of Clinical Endocrinology & Metabolism.
• Stott, D. J., et al. (2019). Thyroid hormone therapy for older adults with subclinical hypothyroidism. The New England Journal of Medicine.
• Hoang, T. D., et al. (2013). Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism. The Journal of Clinical Endocrinology & Metabolism.
• Kelly, D. M., & Jones, T. H. (2015). Testosterone and obesity. Clinical Endocrinology.
• Davis, S. R., & Wahlin-Jacobsen, S. (2015). Testosterone in women: the clinical significance. Clinical Endocrinology.
• Zimmermann, M. B., & Köhrle, J. (2002). The impact of iron and selenium deficiencies on iodine and thyroid metabolism. Endocrine Reviews.
• Docimo, G., et al. (2021). Thyroid hormones, bile acids, and microbiota: An intriguing triangle. Nutrients.
• Winther, K. H., et al. (2020). Selenium in thyroid disorders. The Journal of Clinical Endocrinology & Metabolism.
• Ross, D. S. (2022). Liothyronine (T3) pharmacology and physiological actions. Endotext, NCBI Bookshelf.
• Jonklaas, J., et al. (2019). Thyroid hormone therapy and pharmacokinetics: Clinical considerations. The Journal of Clinical Endocrinology & Metabolism.
• Biondi, B., & Cooper, D. S. (2014). Subclinical thyroid dysfunction and cardiovascular risk: A nuanced view. JAMA.
• CDC. (2023). Adult Obesity Prevalence Maps. Centers for Disease Control and Prevention.
• ChiroMed Clinic. Clinical practice insights from Dr. Alexander Jimenez.
• Jimenez, A. Professional profile and integrative practice perspective.

SEO tags: thyroid optimization, free T3, reverse T3, deiodinase enzymes, levothyroxine, liothyronine, T4 T3 combination therapy, desiccated thyroid, ferritin and thyroid, selenium thyroid, autonomic balance, integrative chiropractic care, HRV thyroid, lab timing thyroid, split dosing T3, Hashimoto’s treatment, metabolic rehabilitation, resistance training hypothyroidism, gut liver thyroid axis, suppressed TSH safety, Dr. Alexander Jimenez,